BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3060153)

  • 1. Testicular cancer.
    Peckham M
    Acta Oncol; 1988; 27(4):439-53. PubMed ID: 3060153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I.
    Fosså SD; Klepp O; Ous S; Lien HH; Stenwig AE; Abyholm T; Kaalhus O
    Eur Urol; 1984; 10(1):17-23. PubMed ID: 6698081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival and quality of life of patients with testicular cancer].
    Lugagne Delpon PM; Petit M; Houlgatte A; Droz JP
    Ann Urol (Paris); 1998; 32(2):80-2. PubMed ID: 9599637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-surgical treatment of testicular cancer: guidelines for the urologist].
    Páez Borda A; Llorente Abarca C; Herrero Payo A; Acebal Lucia J; Berenguer Sánchez A
    Actas Urol Esp; 1993 Apr; 17(4):226-33. PubMed ID: 8393610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy.
    Levitt MD; Reynolds PM; Sheiner HJ; Byrne MJ
    Br J Surg; 1985 Jan; 72(1):19-22. PubMed ID: 2578300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic indications for germinal testicular tumors].
    Bourlaud G; Houlgatte A; Merrer J; Pabot du Chatelard P
    Ann Urol (Paris); 1992; 26(2):119-24. PubMed ID: 1616300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal drug therapy in the treatment of testicular cancer.
    Priest ER; Vogelzang NJ
    Drugs; 1991 Jul; 42(1):52-64. PubMed ID: 1718685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of testicular cancer].
    Droz JP; Boyle H; Culine S; Fizazi K; Fléchon A; Massard C
    Bull Cancer; 2013 Dec; 100(12):1319-32. PubMed ID: 24316884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of testicular seminoma at Westmead Hospital from 1980 to 87.
    Lindeman GJ; Tiver KW
    Aust N Z J Surg; 1991 Mar; 61(3):211-6. PubMed ID: 2003839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal function in men with testicular cancer.
    Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
    Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators for failure of surveillance management of stage I non-seminomatous germ cell tumours.
    Costello AJ; Mortensen PH; Stillwell RG
    Aust N Z J Surg; 1989 Feb; 59(2):119-22. PubMed ID: 2537616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
    Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
    Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
    Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
    Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
    Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
    Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
    Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
    Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
    BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.